English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Statistical Analysis: Analysis of data obtained by independent sample test (t-test) was performed for equality of these mean probability value. Results: Prior treatment pre cycle I; 56.2% of patients were normal, 38.8% with mild anemia and 5.0% were had a moderate anemia. Post cycle I treatment; the normal were declined to only 9.0% and mild anemia were the highest percentage 55% followed by 28.5% for moderate anemia and 7.5% showed severe anemia. Post cycle II about 27.5% of patient showed normal hemoglobin while the majority of them 72.5% had moderate anemia. Conclusion: A correlation of hemoglobin values after completion of therapy to overall treatment was found as a decline in range of (1 to 2 g/dl). Anemia has been demonstrated to be a predictive indicator of response to chemo radiotherapy in lung tumors.

Anemia in Elderly Sudanese Lung Cancer Patients Treated with Chemotherapy~!2010-05-06~!2010-06-28~!2010-07-20~!